PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+1.98%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$7.69B
AUM Growth
+$7.69B
(+2.2%)
Cap. Flow
+$360M
Cap. Flow
% of AUM
4.68%
Top 10 Holdings %
Top 10 Hldgs %
39.16%
Holding
167
New
26
Increased
15
Reduced
34
Closed
16
Top Buys
| 1 |
Nautilus Biotechnolgy
NAUT
|
$90M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$84.7M |
| 3 |
United Therapeutics
UTHR
|
$79.3M |
| 4 |
ZY
Zymergen Inc. Common Stock
ZY
|
$65.3M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$60.1M |
Top Sells
Sector Composition
| 1 | Healthcare | 85.23% |
| 2 | Financials | 0.27% |
| 3 | Industrials | 0.17% |
| 4 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Phreesia
PHR
$1.81B
| – | – |
-100,000
| Closed | -$5.21M |
|
152
Sana Biotechnology
SANA
$721M
| – | – |
-10,000
| Closed | -$335K |
|
153
Syndax Pharmaceuticals
SNDX
$1.37B
| – | – |
-270,000
| Closed | -$6.04M |
|
154
Teladoc Health
TDOC
$1.36B
| – | – |
0
| – | – |
|
155
TherapeuticsMD
TXMD
$12.5M
| – | – |
-2,750,000
| Closed | -$3.69M |
|
|
VINC
156
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| – | – |
-300,000
| Closed | -$5.79M |
|
|
TLIS
157
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| – | – |
-250,000
| Closed | -$3.21M |
|
|
VRAY
158
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-751,748
| Closed | -$3.27M |
|
|
FMTX
159
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| – | – |
-1,250,000
| Closed | -$35M |
|
|
ARNA
160
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-575,007
| Closed | -$39.9M |
|
|
DFHTU
161
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
| – | – |
-300,000
| Closed | -$3.93M |
|
|
VINCW
162
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
| – | – |
-300,000
| Closed | -$1.21M |
|